Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure

Published:2010-03 Issue:3 Volume:25 Page:440-446
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Body Jean-Jacques,Lipton Allan,Gralow Julie,Steger Guenther G,Gao Guozhi,Yeh Howard,Fizazi Karim

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. Skeletal complications of malignancy;Coleman;Cancer,1997

2. Clinical course and prognostic factors following bone recurrence from breast cancer;Coleman;Br J Cancer,1998

3. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel;Aapro;Ann Oncol,2008

4. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial;Rosen;Cancer,2004

5. Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion;Rosen;Cancer,2004

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312);Lung Cancer;2023-08

2. Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review;Translational Pediatrics;2023-03

3. Antiresorptive Medications Prior to Stereotactic Body Radiotherapy for Spinal Metastasis are Associated with Reduced Incidence of Vertebral Body Compression Fracture;Global Spine Journal;2023-02-07

4. Bone metastasis of hepatocellular carcinoma: facts and hopes from clinical and translational perspectives;Frontiers of Medicine;2022-07-19

5. Platinum Nanoparticles in Biomedicine: Preparation, Anti-Cancer Activity, and Drug Delivery Vehicles;Frontiers in Pharmacology;2022-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3